Malaysia Airlines’ MRO arm, MAB Engineering, is testing new technologies in the hangar and adapting its training strategies ...

I-Mab (IMAB) announced that enrollment has been completed ahead of schedule in the first dose expansion cohort in the Phase 1b givastomig combination study, with continued momentum in the second ...

March 07, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment ...